Zacks Research Issues Positive Outlook for Exelixis Earnings
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Zacks Research raised their Q2 2025 EPS estimates for Exelixis in a report released on Tuesday, June 3rd. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will post earnings of $0.52 per share for the quarter, up from their previous forecast of $0.48. The consensus […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Zacks Research raised their Q2 2025 EPS estimates for Exelixis in a report released on Tuesday, June 3rd. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will post earnings of $0.52 per share for the quarter, up from their previous forecast of $0.48. The consensus […]
